Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
Schmid C, Labopin M, Nagler A, Niederwieser D, Castagna L, Tabrizi R, Stadler M, Kuball J, Cornelissen J, Vorlicek J, Socié G, Falda M, Vindeløv L, Ljungman P, Jackson G, Kröger N, Rank A, Polge E, Rocha V, Mohty M; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Schmid C, et al. Among authors: labopin m. Blood. 2012 Feb 9;119(6):1599-606. doi: 10.1182/blood-2011-08-375840. Epub 2011 Dec 13. Blood. 2012. PMID: 22167752 Free article.
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A. Devergie A, et al. Among authors: labopin m. Bone Marrow Transplant. 1997 Jul;20(1):11-9. doi: 10.1038/sj.bmt.1700844. Bone Marrow Transplant. 1997. PMID: 9232250
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ferrant A, Labopin M, Frassoni F, Prentice HG, Cahn JY, Blaise D, Reiffers J, Visani G, Sanz MA, Boogaerts MA, Löwenberg B, Gorin NC. Ferrant A, et al. Among authors: labopin m. Blood. 1997 Oct 15;90(8):2931-8. Blood. 1997. PMID: 9376573 Free article.
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J. Runde V, et al. Among authors: labopin m. Bone Marrow Transplant. 1998 Feb;21(3):255-61. doi: 10.1038/sj.bmt.1701084. Bone Marrow Transplant. 1998. PMID: 9489648 Clinical Trial.
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Cahn JY, Labopin M, Sierra J, Blaise D, Reiffers J, Ferrant A, Bergmann L, Visani G, Cornelissen J, De Witte T, Bosi A, Frassoni F, Gorin NC. Cahn JY, et al. Among authors: labopin m. Br J Haematol. 2000 Aug;110(2):308-14. doi: 10.1046/j.1365-2141.2000.02178.x. Br J Haematol. 2000. PMID: 10971386 Free article.
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).
Fouillard L, Labopin M, Gorin NC, Polge E, Prentice HG, Meloni G, Reiffers J, Pigneux A, Willemze R, Schattenberg A, Sica S, Lagrange M, Fenneteau O, Perot C, Frassoni F; Acute Leukemia Working Party of the EBMT. Fouillard L, et al. Among authors: labopin m. Blood. 2002 Nov 1;100(9):3135-40. doi: 10.1182/blood.V100.9.3135. Blood. 2002. PMID: 12384410 Free article.
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.
Locatelli F, Labopin M, Ortega J, Meloni G, Dini G, Messina C, Yaniv I, Fagioli F, Castel V, Shaw PJ, Ferrant A, Pession A, Sociè G, Frassoni F; European Blood and Marrow Transplantation Acute Leukemia Working Party. Locatelli F, et al. Among authors: labopin m. Blood. 2003 Feb 15;101(4):1611-9. doi: 10.1182/blood-2002-03-0764. Epub 2002 Oct 10. Blood. 2003. PMID: 12393725 Free article.
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
Rocha V, Labopin M, Gluckman E, Powles R, Arcese W, Bacigalupo A, Reiffers J, Iriondo A, Ringdén O, Ruutu T, Frassoni F; Acute Leukemia Working Party of the European Blood and Marrow Transplant Registry. Rocha V, et al. Among authors: labopin m. J Clin Oncol. 2002 Nov 1;20(21):4324-30. doi: 10.1200/JCO.2002.11.058. J Clin Oncol. 2002. PMID: 12409331
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L, Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F. Garderet L, et al. Among authors: labopin m. Bone Marrow Transplant. 2003 Jan;31(1):23-9. doi: 10.1038/sj.bmt.1703778. Bone Marrow Transplant. 2003. PMID: 12621503 Clinical Trial.
524 results